Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy

Annals of the Rheumatic Diseases ◽

10.1136/ard.2006.066605 ◽

2007 ◽

Vol 66 (10) ◽

pp. 1284-1288 ◽

Author(s):

J. Grisar ◽

D. Aletaha ◽

C. W Steiner ◽

T. Kapral ◽

S. Steiner ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Progenitor Cells ◽

Endothelial Progenitor Cells ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Glucocorticoid Therapy ◽

Endothelial Progenitor ◽

Necrosis Factor

Download Full-text

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

10.1016/s0140-6736(12)61424-x ◽

2013 ◽

Vol 381 (9865) ◽

pp. 451-460 ◽

Author(s):

Gerd R Burmester ◽

Ricardo Blanco ◽

Christina Charles-Schoeman ◽

Jürgen Wollenhaupt ◽

Cristiano Zerbini ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Inadequate Response ◽

Phase 3 ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2011-200956 ◽

2012 ◽

Vol 71 (10) ◽

pp. 1671-1679 ◽

Author(s):

Josef S Smolen ◽

Jonathan Kay ◽

Robert B M Landewé ◽

Eric L Matteson ◽

Norman Gaylis ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Previous Experience ◽

Double Blind ◽

Double Blind Placebo ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Tumour necrosis factor blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study

Annals of the Rheumatic Diseases ◽

10.1136/ard.2009.119412 ◽

2009 ◽

Vol 69 (7) ◽

pp. 1281-1285 ◽

Author(s):

M. J. L. Peters ◽

P. Welsh ◽

I. B. McInnes ◽

G. Wolbink ◽

B. A. C. Dijkmans ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cohort Study ◽

Brain Natriuretic Peptide ◽

Tumour Necrosis Factor ◽

Natriuretic Peptide ◽

Prospective Cohort Study ◽

Prospective Cohort ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Necrosis Factor

Download Full-text

Effects of tumour necrosis factor alpha blockade on lipid profile in active rheumatoid arthritis

Rheumatology ◽

10.1093/rheumatology/kem195 ◽

2007 ◽

Vol 46 (10) ◽

pp. 1626-1627 ◽

Author(s):

F. Del Porto ◽

B. Lagana ◽

I. Nofroni ◽

F. Tinti ◽

A. P. Mitterhofer ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Lipid Profile ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Tumour Necrosis Factor Alpha ◽

Necrosis Factor Alpha ◽

Alpha Blockade ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

SAT0115 Tofacitinib Versus Biologic Treatments in Patients with Active Rheumatoid Arthritis Who have had an Inadequate Response to Tumour Necrosis Factor Inhibitors - A Network Meta-Analysis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.1841 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A619.3-A620 ◽

Author(s):

M. C. Vieira ◽

G. Wallenstein ◽

J. Bradley ◽

D. Gruben ◽

T. Koncz ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Inadequate Response ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Serum zinc and copper in active rheumatoid arthritis: Correlation with interleukin 1? and tumour necrosis factor ?

Clinical Rheumatology ◽

10.1007/bf01450895 ◽

1998 ◽

Vol 17 (5) ◽

pp. 378-382 ◽

Author(s):

A. Zoli ◽

L. Altomonte ◽

R. Caricchio ◽

A. Galossi ◽

L. Mirone ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Interleukin 1 ◽

Necrosis Factor

Download Full-text

Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-203435 ◽

2013 ◽

Vol 73 (10) ◽

pp. 1811-1818 ◽

Author(s):

Josef S Smolen ◽

Jonathan Kay ◽

Eric L Matteson ◽

Robert Landewé ◽

Elizabeth C Hsia ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Factor Therapy ◽

Post Hoc ◽

Necrosis Factor

Download Full-text

Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima–media thickness in female patients with active rheumatoid arthritis

Rheumatology International ◽

10.1007/s00296-009-0935-2 ◽

2009 ◽

Vol 30 (2) ◽

pp. 193-198 ◽

Author(s):

A. Ferrante ◽

A. R. Giardina ◽

F. Ciccia ◽

G. Parrinello ◽

G. Licata ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Intima Media Thickness ◽

Carotid Intima Media Thickness ◽

Media Thickness ◽

Factor Therapy ◽

Necrosis Factor

Download Full-text

Golimumab, a human antibody to tumour necrosis factor given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

Annals of the Rheumatic Diseases ◽

10.1136/ard.2008.099010 ◽

2008 ◽

Vol 68 (6) ◽

pp. 789-796 ◽

Author(s):

E C Keystone ◽

M C Genovese ◽

L Klareskog ◽

E C Hsia ◽

S T Hall ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Methotrexate Therapy ◽

Human Antibody ◽

Subcutaneous Injections ◽

Necrosis Factor

Download Full-text

Cost-utility analysis of certolizumab pegol versus alternative tumour necrosis factor inhibitors available for the treatment of moderate-to-severe active rheumatoid arthritis in Spain

Cost Effectiveness and Resource Allocation ◽

10.1186/s12962-015-0037-9 ◽

2015 ◽

Vol 13 (1) ◽

Author(s):

Álvaro Hidalgo-Vega ◽

Renata Villoro ◽

Juan Antonio Blasco ◽

Pablo Talavera ◽

Belén Ferro ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Certolizumab Pegol ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text